ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
HEMOGENYX PHARMACEUTICALS PLC: cashflow_financing
One fact, its scope and the complete path back to the official record.
Reported value
-110.144k{"amount": -110144.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"}- Metric
- cashflow_financing
- Period
- 2022-01-01 – 2022-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:2138008L93GYU5GN6179:2023-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T23:51:57.979189+02:00
Raw response SHA-256
9c8c4432619f98cd9933ba7378b9061f…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.